Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Thomas Kim
President & CEO
tkim@epivario.com

Message the company or request a 1:1 meeting here

EpiVario Inc. is a preclinical stage biotechnology company spun out from the University of Pennsylvania School of Medicine, harnessing neuroepigenetics expertise to treat addiction and anxiety disorders. EpiVario is focused on developing innovative epigenetic therapeutics to treat complex memory-related neuropsychiatric disorders by targeting a newly discovered epigenetic mechanism involved in long term memory. Epivario is thereby developing a first-in-class therapeutic for nicotine addiction.

Pitch Video

Executive Summary